A recent study in the Journal of the American Medical Association (JAMA) has concluded that R&D costs a company just $648 million on average to bring a cancer drug to the market — a small fraction of the $2.7 billion…
A recent study in the Journal of the American Medical Association (JAMA) has concluded that R&D costs a company just $648 million on average to bring a cancer drug to the market — a small fraction of the $2.7 billion…